SKANSKA SIGNS $130M CONTRACT FOR RESEARCH CAMPUS EXPANSION

by admin

CAMBRIDGE, MASS. — Skanska has signed a $130 million contract with Novartis for the expansion of its pharmaceutical research campus in Cambridge, about three miles west of Boston. Novartis, a pharmaceutical company based in Basel, Switzerland, is an existing client of Skanska. The initial work on the project began in 2012 and the expansion will be completed in 2015.

You may also like